塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/20 | 6,346 | 6,432 | 6,315 | 6,415 | +97 | +1.5% | 849,500 |
2019/05/17 | 6,378 | 6,390 | 6,294 | 6,318 | -12 | -0.2% | 943,300 |
2019/05/16 | 6,350 | 6,355 | 6,289 | 6,330 | +7 | +0.1% | 872,400 |
2019/05/15 | 6,434 | 6,439 | 6,311 | 6,323 | -190 | -2.9% | 1,116,400 |
2019/05/14 | 6,368 | 6,520 | 6,345 | 6,513 | +45 | +0.7% | 836,400 |
2019/05/13 | 6,563 | 6,571 | 6,360 | 6,468 | -183 | -2.8% | 1,025,800 |
2019/05/10 | 6,699 | 6,758 | 6,595 | 6,651 | +152 | +2.3% | 1,843,000 |
2019/05/09 | 6,520 | 6,588 | 6,406 | 6,499 | -51 | -0.8% | 2,025,800 |
2019/05/08 | 6,529 | 6,567 | 6,495 | 6,550 | -24 | -0.4% | 1,307,600 |
2019/05/07 | 6,445 | 6,587 | 6,417 | 6,574 | +98 | +1.5% | 1,193,100 |
2019/04/26 | 6,403 | 6,480 | 6,400 | 6,476 | +50 | +0.8% | 705,800 |
2019/04/25 | 6,393 | 6,436 | 6,371 | 6,426 | +91 | +1.4% | 743,400 |
2019/04/24 | 6,446 | 6,475 | 6,310 | 6,335 | -52 | -0.8% | 902,400 |
2019/04/23 | 6,353 | 6,406 | 6,337 | 6,387 | +88 | +1.4% | 920,800 |
2019/04/22 | 6,280 | 6,346 | 6,228 | 6,299 | -30 | -0.5% | 724,500 |
2019/04/19 | 6,350 | 6,360 | 6,278 | 6,329 | -94 | -1.5% | 1,387,700 |
2019/04/18 | 6,600 | 6,632 | 6,409 | 6,423 | -200 | -3% | 1,491,900 |
2019/04/17 | 6,615 | 6,646 | 6,544 | 6,623 | +8 | +0.1% | 1,227,500 |
2019/04/16 | 6,521 | 6,658 | 6,493 | 6,615 | +94 | +1.4% | 1,514,800 |
2019/04/15 | 6,580 | 6,590 | 6,483 | 6,521 | -62 | -0.9% | 1,293,700 |
2019/04/12 | 6,645 | 6,647 | 6,531 | 6,583 | +37 | +0.6% | 1,568,700 |
2019/04/11 | 6,484 | 6,575 | 6,463 | 6,546 | +96 | +1.5% | 1,263,400 |
2019/04/10 | 6,479 | 6,533 | 6,404 | 6,450 | -93 | -1.4% | 902,300 |
2019/04/09 | 6,500 | 6,554 | 6,435 | 6,543 | -26 | -0.4% | 1,201,300 |
2019/04/08 | 6,592 | 6,596 | 6,503 | 6,569 | -23 | -0.3% | 772,200 |
2019/04/05 | 6,573 | 6,634 | 6,540 | 6,592 | -31 | -0.5% | 972,800 |
2019/04/04 | 6,787 | 6,794 | 6,606 | 6,623 | -153 | -2.3% | 1,119,700 |
2019/04/03 | 6,838 | 6,842 | 6,710 | 6,776 | -19 | -0.3% | 1,053,300 |
2019/04/02 | 6,905 | 6,913 | 6,780 | 6,795 | -57 | -0.8% | 880,200 |
2019/04/01 | 6,969 | 6,990 | 6,817 | 6,852 | ±0 | ±0% | 1,178,100 |
2019/03/29 | 6,770 | 6,859 | 6,770 | 6,852 | +135 | +2% | 1,058,800 |
2019/03/28 | 6,714 | 6,768 | 6,627 | 6,717 | -191 | -2.8% | 2,331,200 |
2019/03/27 | 6,830 | 6,917 | 6,813 | 6,908 | +167 | +2.5% | 1,532,300 |
2019/03/26 | 6,600 | 6,768 | 6,552 | 6,741 | +293 | +4.5% | 1,568,400 |
2019/03/25 | 6,605 | 6,637 | 6,428 | 6,448 | -236 | -3.5% | 1,286,700 |
2019/03/22 | 6,860 | 6,860 | 6,651 | 6,684 | -153 | -2.2% | 1,443,300 |
2019/03/20 | 6,796 | 6,845 | 6,775 | 6,837 | -22 | -0.3% | 1,126,900 |
2019/03/19 | 6,841 | 6,860 | 6,777 | 6,859 | +22 | +0.3% | 599,800 |
2019/03/18 | 6,830 | 6,855 | 6,791 | 6,837 | +20 | +0.3% | 651,700 |
2019/03/15 | 6,727 | 6,838 | 6,722 | 6,817 | +110 | +1.6% | 1,136,800 |
2019/03/14 | 6,800 | 6,817 | 6,701 | 6,707 | -8 | -0.1% | 1,004,700 |
2019/03/13 | 6,650 | 6,720 | 6,650 | 6,715 | -4 | -0.1% | 1,037,100 |
2019/03/12 | 6,756 | 6,770 | 6,705 | 6,719 | +43 | +0.6% | 1,053,800 |
2019/03/11 | 6,648 | 6,735 | 6,648 | 6,676 | +28 | +0.4% | 896,500 |
2019/03/08 | 6,744 | 6,771 | 6,641 | 6,648 | -144 | -2.1% | 1,826,300 |
2019/03/07 | 6,829 | 6,882 | 6,789 | 6,792 | -65 | -0.9% | 1,278,400 |
2019/03/06 | 6,938 | 6,963 | 6,831 | 6,857 | -143 | -2% | 1,655,900 |
2019/03/05 | 6,972 | 7,019 | 6,949 | 7,000 | -32 | -0.5% | 1,295,700 |
2019/03/04 | 7,160 | 7,169 | 7,010 | 7,032 | -63 | -0.9% | 1,424,200 |
2019/03/01 | 7,075 | 7,145 | 7,070 | 7,095 | -21 | -0.3% | 788,900 |
1351~
1400
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム